General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents | Tenderlake

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
28 July 2023
Closing Date:
22 August 2023
Location(s):
FI1D9 Pohjois-Pohjanmaa (FI Finland/SUOMI / FINLAND)
Description:
Monoclonal antibodies for the period 1.1-31.12.2024 + option year 2025

The target of the procurement are monoclonal antibodies belonging to the ATC group L01F and combined preparations containing only monoclonal antibodies within the ATC group L01XY. The medicinal products offered must have a marketing authorisation in Finland and be marketed and available in Finland on 1.1.2024.

The target of the procurement are monoclonal antibodies belonging to the ATC group L01F and combined preparations containing only monoclonal antibodies within the ATC group L01XY. The medicinal products offered must have a marketing authorisation in Finland and be marketed and available in Finland on 1.1.2024.

Download full details as .pdf
The Buyer:
Pohjois-Pohjanmaan hyvinvointialue
CPV Code(s):
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents